Utility of a commercial nonstructural protein 1 antigen capture kit as a dengue virus diagnostic tool.
Annually, over 2.5 billion people are at risk for infection with dengue virus (DENV), while between 50 and 100 million people contract the infection. There is an urgent need for alternative diagnostic tools that can detect DENV during acute infection. Recent studies have shown that DENV nonstructural protein 1 (NS1) is detectable in the blood as early as the onset of symptoms and persists well into the convalescent phase of the infection. We evaluated the utility of the Bio-Rad Platelia DENV NS1 antigen capture kit in combination with real-time reverse transcriptase PCR (RT-PCR) and an IgM antibody capture enzyme-linked immunosorbent assay (MAC-ELISA) for refining a new algorithm for the diagnosis of acute- or convalescent-phase DENV infection with a single clinical sample. We tested the Bio-Rad kit with three panels of sera. These panels were designed to evaluate the sensitivities of the NS1 kit for (i) early-convalescent-phase samples, (ii) acute-phase samples with false-negative PCR results, and (iii) IgM-negative convalescent-phase samples from patients with confirmed secondary DENV infections. Results show that NS1 can be detected in 22% of serum samples collected more than 10 days after the onset of illness and in 22% of samples that did not elicit an IgM response. Additionally, NS1 was detected in 37% of the tested acute-phase samples with false-negative PCR results, suggesting that NS1 detection may be valuable in increasing the sensitivity of current acute-phase diagnostics. These results will improve diagnosis with a single acute-phase or early-convalescent-phase sample for disease surveillance and clinical diagnosis.
Bessoff
Kovi
K
Public Health Service, CDC-Dengue Branch, 1324 Calle Cañada, San Juan, PR 00920.
Phoutrides
Elena
E
Delorey
Mark
M
Acosta
Luz N
LN
Hunsperger
Elizabeth
E
D000465:Algorithms; D000818:Animals; D000956:Antigens, Viral / Q000097:blood*; D002460:Cell Line; D003715:Dengue / Q000175:diagnosis* / Q000503:physiopathology / Q000821:virology; D003716:Dengue Virus / Q000276:immunology / Q000302:isolation & purification*; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D011933:Reagent Kits, Diagnostic; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012680:Sensitivity and Specificity; D017361:Viral Nonstructural Proteins / Q000097:blood*
D000956:Antigens, Viral; D007075:Immunoglobulin M; D011933:Reagent Kits, Diagnostic; D017361:Viral Nonstructural Proteins
PLoS Negl Trop Dis. 2008 Aug 20;2(8):e280
18714359
Southeast Asian J Trop Med Public Health. 1987 Sep;18(3):392-7
3433169
J Virol Methods. 2007 Mar;140(1-2):75-9
17140671
Clin Vaccine Immunol. 2008 Oct;15(10):1513-8
18685015
Diagn Microbiol Infect Dis. 2008 Jan;60(1):43-9
17889487
PLoS Negl Trop Dis. 2009;3(1):e360
19156192
J Clin Virol. 1999 Dec;14(3):183-9
10614855
Diagn Microbiol Infect Dis. 2009 May;64(1):31-6
19232865
Emerg Infect Dis. 2009 Mar;15(3):436-40
19239758
J Clin Microbiol. 2006 Apr;44(4):1295-304
16597854
Diagn Microbiol Infect Dis. 2008 Apr;60(4):387-91
18191361
J Virol Methods. 2009 Feb;155(2):157-60
19022293
J Clin Microbiol. 2006 Aug;44(8):2872-8
16891505
Am J Trop Med Hyg. 1984 Jan;33(1):158-65
6364855
J Clin Microbiol. 1982 Dec;16(6):1034-42
7161371
J Infect Dis. 1997 Aug;176(2):322-30
9237696
Clin Microbiol Rev. 1998 Jul;11(3):480-96
9665979
J Clin Microbiol. 1999 Aug;37(8):2543-7
10405398
Ann Acad Med Singap. 1998 Mar;27(2):227-34
9663316
Epidemiol Infect. 2006 Aug;134(4):820-5
16371180
Am J Trop Med Hyg. 1989 Apr;40(4):418-27
2540664